Kiniksa Pharmaceuticals International Plc (KNSA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 03-2018 | 12-2017 | 09-2017 | 06-2017 | 12-2016 | |
| Operating Expenses | 16,340 | 0 | 16,249 | 11,392 | 0 |
| Operating Income | -16,340 | N/A | -16,249 | -11,392 | N/A |
| Other Income | 305 | 0 | 169 | 153 | 0 |
| Pre-tax Income | -16,035 | 0 | -16,080 | -11,239 | 0 |
| Income Tax | -53 | N/A | -51 | -36 | N/A |
| Net Income Continuous | -15,982 | N/A | -16,029 | -11,203 | N/A |
| Net Income | $-15,982 | $N/A | $-16,029 | $-11,203 | $N/A |
| EPS Basic Total Ops | -6.45 | N/A | -8.25 | -6.69 | N/A |
| EPS Basic Continuous Ops | -6.45 | N/A | -8.25 | -6.69 | N/A |
| EPS Diluted Total Ops | -6.45 | N/A | -8.25 | -6.69 | N/A |
| EPS Diluted Continuous Ops | -6.45 | N/A | -8.25 | -6.69 | N/A |
| EBITDA(a) | $-16,332 | $N/A | $-16,241 | $-11,392 | $N/A |